Sofosbuvir/Velpatasvir for 12 Weeks in Genotype 1-4 HCV-Infected Liver Transplant Recipients

被引：0

作者：

Agarwal, Kosh ^{[1
]}

Castells, Lluis ^{[2
]}

Mullhaupt, Beat ^{[3
]}

Rosenberg, William M. ^{[4
]}

McNabb, Brian L. ^{[5
]}

Arterburn, Sarah ^{[6
]}

Camus, Gregory ^{[7
]}

McNally, John ^{[5
]}

Brainard, Diana M. ^{[5
]}

Subramanian, Mani ^{[5
]}

Gonsalkorala, Enoka ^{[1
]}

Londono, Maria ^{[8
,9
]}

Dufour, Jean-Francois ^{[10
]}

Forns, Xavier ^{[8
,9
]}

机构：

[1] Kings Coll Hosp NHS Trust Fdn, London, England

[2] Hosp Univ Val dHebron, Barcelona, Spain

[3] Univ Hosp Zurich, Zurich, Switzerland

[4] UCL, Inst Liver & Digest Hlth, London, England

[5] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[6] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[7] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[8] Hosp Clin Barcelona, CIBEREHD, Barcelona, Spain

[9] IDIBAPS, Barcelona, Spain

[10] Univ Bern, Bern, Switzerland

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1069

引用

页码：571A / 571A

页数：1

共 50 条

[41] SAFETY AND EFFICACY OF TREATMENT WITH ONCE-DAILY LEDIPASVIR/SOFOSBUVIR (90/400 MG) FOR 12 WEEKS IN GENOTYPE 1 HCV-INFECTED PATIENTS WITH SEVERE RENAL IMPAIRMENT [J].

Lawitz, Eric ;

Landis, Charles S. ;

Maliakkal, Benedict J. ;

Bonacini, Maurizio ;

Ortiz-Lasanta, Grisell ;

Zhang, Jie ;

Mogalian, Erik ;

De-Oertel, Shampa ;

Osinusi, Anu O. ;

Brainard, Diana M. ;

McHutchison, John G. ;

Yip, Christina Sze Man ;

Huang, Hai Cheng ;

Flamm, Steven L. ;

Gordon, Stuart C. ;

Gane, Edward J. .

GUT, 2018, 67 :A99-A100

[42] Safety and Efficacy of Treatment with Once-Daily Ledipasvir/Sofosbuvir (90/400 mg) for 12 Weeks in Genotype 1 HCV-Infected Patients with Severe Renal Impairment [J].

Lawitz, Eric ;

Landis, Charles S. ;

Maliakkal, Benedict J. ;

Bonacini, Maurizio ;

Ortiz-Lasanta, Grisell ;

Zhang, Jie ;

Mogalian, Erik ;

De-Oertel, Shampa ;

Osinusi, Anu O. ;

Brainard, Diana M. ;

McHutchison, John G. ;

Flamm, Steven L. ;

Gordon, Stuart C. ;

Gane, Edward J. .

HEPATOLOGY, 2017, 66 :848A-848A

[43] Contribution of donor liver steatosis to graft survival and viral recurrence in HCV-infected liver transplant recipients [J].

Briceno, J. ;

Ciria, R. ;

Pleguezuelo, M. ;

Lopez-Cillero, P. ;

Rufian, S. ;

Lopez-Rubio, F. ;

Mata, M. .

JOURNAL OF HEPATOLOGY, 2007, 46 :S64-S64

[44] NO IMPACT OF OBESITY ON POST-LIVER TRANSPLANTATION OUTCOME AMONG HCV-INFECTED LIVER TRANSPLANT RECIPIENTS [J].

Torres-Quevedo, R. ;

Aguilera, V. ;

Rubin, A. ;

San Juan, F. ;

Moya, A. ;

Prieto, M. ;

Mir, J. ;

Berenguer, M. .

JOURNAL OF HEPATOLOGY, 2010, 52 :S183-S183

[45] Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States [J].

Bowring, Mary Grace ;

Shaffer, Ashton ;

Massie, Allan ;

Desai, Niraj ;

Sulkowski, Mark ;

Segev, Dorry .

AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 :14-15

[46] Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors [J].

Chen, Ruoyang ;

Li, Dawei ;

Zhang, Ming ;

Yuan, Xiaodong .

ANNALS OF TRANSPLANTATION, 2021, 26

[47] Impact of primary immunosuppression on allograft histology and viral levels in HCV-infected liver transplant recipients [J].

Charlton, MR ;

Luna, LM ;

Gonzalez-Koch, AR ;

Poterucha, JJ ;

Maor-Kendler, Y ;

Batts, KP ;

Wiesner, RH ;

Rosen, CB ;

Raghavakaimal, S .

HEPATOLOGY, 1999, 30 (04) :658A-658A

[48] Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients [J].

Berenguer, Marina ;

Aguilera, Victoria ;

Prieto, Martin ;

San Juan, Fernando ;

Rayon, Jose M. ;

Benlloch, Salvador ;

Berenguer, Joaquin .

LIVER TRANSPLANTATION, 2006, 12 (05) :762-767

[49] Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection [J].

Colombo, Massimo ;

Aghemo, Alessio ;

Liu, Hong ;

Zhang, Jie ;

Dvory-Sobol, Hadas ;

Hyland, Robert ;

Yun, Chohee ;

Massetto, Benedetta ;

Brainard, Diana M. ;

McHutchison, John G. ;

Bourliere, Marc ;

Peck-Radosavljevic, Markus ;

Manns, Michael ;

Pol, Stanislas .

ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) :109-+

[50] SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAIVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY [J].

Kowdley, K. V. ;

Stuart, G. C. ;

Reddy, R. K. ;

Rossaro, L. ;

Bernstein, D. E. ;

An, D. ;

Svarovskaia, E. S. ;

Hyland, R. H. ;

Pang, P. S. ;

Symonds, W. T. ;

Mchutchison, J. G. ;

Muir, A. J. ;

Pockros, P. J. ;

Pound, D. ;

Fried, M. W. .

JOURNAL OF HEPATOLOGY, 2014, 60 (01) :S23-S24

← 1 2 3 4 5 →